Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 23 | 2024 | 3836 | 1.260 |
Why?
|
Proteome | 11 | 2023 | 1856 | 0.880 |
Why?
|
Mass Spectrometry | 12 | 2021 | 2189 | 0.780 |
Why?
|
Drug Recalls | 1 | 2020 | 20 | 0.710 |
Why?
|
Pneumonia, Bacterial | 2 | 2021 | 316 | 0.650 |
Why?
|
Drug Contamination | 1 | 2020 | 151 | 0.650 |
Why?
|
Carcinogens | 1 | 2020 | 452 | 0.600 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 431 | 0.580 |
Why?
|
Quality Control | 1 | 2020 | 834 | 0.580 |
Why?
|
Virus Diseases | 1 | 2021 | 716 | 0.500 |
Why?
|
Cough | 1 | 2019 | 594 | 0.500 |
Why?
|
Phenethylamines | 1 | 2014 | 95 | 0.470 |
Why?
|
Blood Volume | 1 | 2015 | 547 | 0.460 |
Why?
|
Malaria | 2 | 2021 | 1225 | 0.460 |
Why?
|
Drug Industry | 1 | 2020 | 788 | 0.450 |
Why?
|
Drug Approval | 1 | 2020 | 812 | 0.430 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 830 | 0.420 |
Why?
|
Triage | 1 | 2019 | 984 | 0.410 |
Why?
|
HIV Integrase Inhibitors | 1 | 2014 | 165 | 0.400 |
Why?
|
Phosphoproteins | 6 | 2021 | 2443 | 0.390 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1661 | 0.390 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 287 | 0.380 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 2746 | 0.340 |
Why?
|
Inpatients | 1 | 2020 | 2545 | 0.320 |
Why?
|
Heparin | 1 | 2015 | 1632 | 0.300 |
Why?
|
Blood Proteins | 4 | 2017 | 1172 | 0.300 |
Why?
|
Protein Processing, Post-Translational | 4 | 2023 | 1967 | 0.300 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11475 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3216 | 0.260 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13382 | 0.260 |
Why?
|
Body Weight | 1 | 2015 | 4618 | 0.240 |
Why?
|
Chloride Channels | 2 | 1996 | 221 | 0.240 |
Why?
|
Sulfonamides | 1 | 2014 | 1977 | 0.240 |
Why?
|
Veterans | 2 | 2015 | 2652 | 0.230 |
Why?
|
Insufflation | 2 | 2001 | 63 | 0.220 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 982 | 0.200 |
Why?
|
Leukocytosis | 2 | 2014 | 251 | 0.200 |
Why?
|
Neoplasms | 8 | 2024 | 22125 | 0.180 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2022 | 284 | 0.170 |
Why?
|
Peptide Fragments | 1 | 2013 | 5103 | 0.170 |
Why?
|
Anticoagulants | 1 | 2015 | 4795 | 0.170 |
Why?
|
Respiration, Artificial | 2 | 2001 | 2630 | 0.170 |
Why?
|
Proteins | 2 | 2023 | 5993 | 0.170 |
Why?
|
Brain Ischemia | 4 | 2014 | 3031 | 0.160 |
Why?
|
Gene Expression Profiling | 8 | 2018 | 9416 | 0.160 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6504 | 0.160 |
Why?
|
Breast Neoplasms | 8 | 2020 | 20981 | 0.160 |
Why?
|
Peptide Mapping | 2 | 2011 | 259 | 0.160 |
Why?
|
DNA Copy Number Variations | 3 | 2023 | 2024 | 0.150 |
Why?
|
Humans | 57 | 2024 | 761098 | 0.150 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2018 | 146 | 0.150 |
Why?
|
Ovarian Neoplasms | 4 | 2023 | 4853 | 0.150 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2813 | 0.140 |
Why?
|
Hemorrhage | 2 | 2022 | 3422 | 0.140 |
Why?
|
Blood Chemical Analysis | 2 | 2011 | 436 | 0.140 |
Why?
|
Biomedical Research | 1 | 2013 | 3429 | 0.140 |
Why?
|
Phosphorylation | 7 | 2023 | 8303 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 447 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2018 | 899 | 0.130 |
Why?
|
Heart Failure | 1 | 2020 | 11701 | 0.130 |
Why?
|
Lung Injury | 1 | 2001 | 422 | 0.130 |
Why?
|
Protein Kinases | 3 | 2020 | 1607 | 0.130 |
Why?
|
Intubation, Intratracheal | 2 | 2001 | 1331 | 0.130 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 1007 | 0.130 |
Why?
|
Stents | 2 | 2018 | 3177 | 0.130 |
Why?
|
Retina | 2 | 1996 | 2656 | 0.120 |
Why?
|
Molecular Sequence Annotation | 2 | 2016 | 518 | 0.120 |
Why?
|
Morpholines | 1 | 2018 | 581 | 0.120 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2553 | 0.120 |
Why?
|
Tetrazoles | 1 | 2020 | 909 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 2048 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 353 | 0.110 |
Why?
|
Aminopyridines | 1 | 2018 | 573 | 0.110 |
Why?
|
Plasma | 1 | 2017 | 586 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1039 | 0.110 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 1995 | 204 | 0.110 |
Why?
|
Workflow | 4 | 2023 | 850 | 0.110 |
Why?
|
Cold Ischemia | 1 | 2014 | 70 | 0.110 |
Why?
|
Pathology, Molecular | 1 | 2017 | 329 | 0.110 |
Why?
|
Antibodies, Bacterial | 1 | 2019 | 1463 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2018 | 677 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 346 | 0.100 |
Why?
|
Mutation | 5 | 2021 | 30006 | 0.100 |
Why?
|
Piperazines | 2 | 2014 | 2522 | 0.100 |
Why?
|
Drug Interactions | 2 | 2014 | 1417 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 2 | 1996 | 1140 | 0.100 |
Why?
|
Receptors, GABA-A | 1 | 1996 | 621 | 0.100 |
Why?
|
Oxazines | 1 | 2014 | 349 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1605 | 0.100 |
Why?
|
Glycine | 1 | 1995 | 659 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3591 | 0.100 |
Why?
|
Ticlopidine | 1 | 2016 | 730 | 0.100 |
Why?
|
Computational Biology | 3 | 2018 | 3499 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1213 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58946 | 0.090 |
Why?
|
Stroke | 4 | 2014 | 9720 | 0.090 |
Why?
|
Acetanilides | 1 | 2012 | 169 | 0.090 |
Why?
|
Aged | 13 | 2022 | 169266 | 0.090 |
Why?
|
Genomics | 4 | 2024 | 5828 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2014 | 774 | 0.090 |
Why?
|
Acetylation | 2 | 2023 | 1050 | 0.080 |
Why?
|
Blood Coagulation | 1 | 2015 | 1156 | 0.080 |
Why?
|
Cohort Studies | 4 | 2022 | 41486 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1521 | 0.080 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2016 | 1724 | 0.080 |
Why?
|
Pyridones | 1 | 2014 | 809 | 0.080 |
Why?
|
Nervous System | 1 | 2012 | 545 | 0.080 |
Why?
|
DNA Methylation | 2 | 2020 | 4386 | 0.080 |
Why?
|
Specimen Handling | 1 | 2013 | 701 | 0.080 |
Why?
|
Female | 26 | 2023 | 392458 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1615 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2316 | 0.080 |
Why?
|
Pneumonia | 2 | 2017 | 2142 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2015 | 968 | 0.070 |
Why?
|
Signal Transduction | 7 | 2021 | 23415 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8529 | 0.070 |
Why?
|
Male | 17 | 2023 | 360675 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2175 | 0.070 |
Why?
|
Respiratory Mechanics | 2 | 2001 | 699 | 0.070 |
Why?
|
Stroke Volume | 1 | 2020 | 5520 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2021 | 4021 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3594 | 0.070 |
Why?
|
United States | 6 | 2021 | 72337 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2015 | 1312 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2022 | 80673 | 0.060 |
Why?
|
Smoking | 2 | 2021 | 9055 | 0.060 |
Why?
|
Reproducibility of Results | 7 | 2016 | 20120 | 0.060 |
Why?
|
Biological Assay | 1 | 2008 | 623 | 0.060 |
Why?
|
Lung | 2 | 2020 | 9979 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2012 | 1834 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2006 | 399 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2021 | 2706 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16572 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2022 | 64670 | 0.060 |
Why?
|
Middle Aged | 11 | 2021 | 220835 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4245 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2010 | 0.050 |
Why?
|
Databases, Protein | 2 | 2018 | 386 | 0.050 |
Why?
|
Peptides | 4 | 2023 | 4353 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2015 | 2191 | 0.050 |
Why?
|
Fallopian Tubes | 1 | 2023 | 178 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1663 | 0.050 |
Why?
|
United States Department of Veterans Affairs | 2 | 2018 | 928 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 43 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2018 | 16947 | 0.050 |
Why?
|
Acidosis, Respiratory | 1 | 2001 | 37 | 0.050 |
Why?
|
Barotrauma | 1 | 2001 | 39 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 178 | 0.050 |
Why?
|
High-Frequency Jet Ventilation | 1 | 2001 | 26 | 0.050 |
Why?
|
Tumor Escape | 1 | 2024 | 371 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2023 | 330 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3776 | 0.040 |
Why?
|
Embolism, Air | 1 | 2001 | 110 | 0.040 |
Why?
|
High-Frequency Ventilation | 1 | 2001 | 88 | 0.040 |
Why?
|
Genome, Human | 1 | 2013 | 4423 | 0.040 |
Why?
|
Systems Integration | 2 | 2013 | 428 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2005 | 610 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3245 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2006 | 993 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2011 | 0.040 |
Why?
|
Rabbits | 2 | 1996 | 4749 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 793 | 0.040 |
Why?
|
Hypercapnia | 1 | 2001 | 261 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2001 | 748 | 0.040 |
Why?
|
Animals | 12 | 2018 | 168083 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24013 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1518 | 0.040 |
Why?
|
Tidal Volume | 1 | 2001 | 488 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2001 | 288 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 348 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74219 | 0.040 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2018 | 112 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2864 | 0.040 |
Why?
|
Child | 3 | 2021 | 80134 | 0.040 |
Why?
|
Adult | 7 | 2021 | 221083 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1220 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 559 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2001 | 411 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9025 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2020 | 671 | 0.030 |
Why?
|
Models, Genetic | 1 | 2007 | 3430 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2001 | 638 | 0.030 |
Why?
|
Ubiquitination | 1 | 2021 | 1004 | 0.030 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2016 | 32 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1227 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 736 | 0.030 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2016 | 89 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2016 | 120 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14676 | 0.030 |
Why?
|
Receptors, Interleukin-10 | 1 | 2016 | 50 | 0.030 |
Why?
|
Mice | 7 | 2018 | 81324 | 0.030 |
Why?
|
Pilot Projects | 3 | 2020 | 8639 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2016 | 145 | 0.030 |
Why?
|
p21-Activated Kinases | 1 | 2016 | 127 | 0.030 |
Why?
|
Immunotherapy | 2 | 2021 | 4642 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13630 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.030 |
Why?
|
Haptoglobins | 1 | 2016 | 165 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 741 | 0.030 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2013 | 22 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2016 | 344 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 769 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1702 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2820 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2016 | 535 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6305 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7574 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 987 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2570 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1995 | 925 | 0.030 |
Why?
|
Equipment Design | 1 | 2001 | 3509 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 655 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2915 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1996 | 1463 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 931 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2014 | 393 | 0.030 |
Why?
|
Gene Library | 1 | 2015 | 1055 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5425 | 0.030 |
Why?
|
Immunoassay | 1 | 2016 | 743 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 296 | 0.020 |
Why?
|
Membrane Potentials | 1 | 1995 | 1089 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8519 | 0.020 |
Why?
|
Benchmarking | 1 | 2018 | 1045 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1480 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1066 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2016 | 1386 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2041 | 0.020 |
Why?
|
Prognosis | 3 | 2021 | 29672 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1658 | 0.020 |
Why?
|
Infant | 3 | 2018 | 36164 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2443 | 0.020 |
Why?
|
Algorithms | 2 | 2013 | 14023 | 0.020 |
Why?
|
Nitroglycerin | 1 | 2012 | 330 | 0.020 |
Why?
|
Research Design | 2 | 2018 | 6178 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15845 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10213 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42217 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1822 | 0.020 |
Why?
|
RNA Interference | 1 | 2018 | 2816 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9300 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7567 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3409 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2016 | 1249 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2012 | 5296 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2014 | 1162 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1741 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3819 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1636 | 0.020 |
Why?
|
Blood Glucose | 2 | 2012 | 6390 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17349 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3869 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2513 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2012 | 989 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59199 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2001 | 12743 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1242 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3419 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39121 | 0.020 |
Why?
|
Normal Distribution | 1 | 2006 | 272 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2381 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2914 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2014 | 2055 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1528 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3582 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18217 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5662 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2001 | 6340 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5781 | 0.010 |
Why?
|
Calibration | 1 | 2006 | 819 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4849 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 713 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2406 | 0.010 |
Why?
|
Hospitalization | 2 | 2012 | 10712 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23713 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11732 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11066 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2528 | 0.010 |
Why?
|
Disease Progression | 2 | 2012 | 13506 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12975 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9648 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1995 | 18926 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10755 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2001 | 420 | 0.010 |
Why?
|
Patient Discharge | 1 | 2012 | 3441 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12983 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6420 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6385 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13254 | 0.010 |
Why?
|
Genome | 1 | 2005 | 1737 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2691 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9317 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26187 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1549 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 39953 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15308 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18385 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2006 | 3568 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54419 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14393 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2001 | 4908 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 88271 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2005 | 3609 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22129 | 0.000 |
Why?
|
Survival Rate | 1 | 2001 | 12727 | 0.000 |
Why?
|